These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5881526)

  • 1. [Progressive muscular dystrophy. VII. Detection of heterozygotes of Duehenne muscular dystrophy by determining serum creatine kinase with localized work load in anoxia].
    Wiesmann U; Moser H; Richterich R; Rossi E
    Klin Wochenschr; 1965 Oct; 43(19):1015-22. PubMed ID: 5881526
    [No Abstract]   [Full Text] [Related]  

  • 2. The significance of the dilution effect in serum creatine kinase diagnosis of muscular dystrophy.
    Spikesman AM; Brock DJ
    Clin Chim Acta; 1969 Dec; 26(3):387-9. PubMed ID: 5358538
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum creatine kinase studies in the detection of carriers of Duchenne dystrophy.
    Hughes RC; Park DC; Parsons ME; O'Brien MD
    J Neurol Neurosurg Psychiatry; 1971 Oct; 34(5):527-30. PubMed ID: 4941478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Critical evaluation of changes of serum CK after exertion in the identification of carriers of Duchenne's muscular dystrophy].
    Cordone G; Venzano V; Rossi G; Cavallero G; Minetti C
    Pediatr Med Chir; 1984; 6(6):819-22. PubMed ID: 6545595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Enzyme diagnosis in progressive muscular dystrophies, especially in the Duchenne type].
    Pernice W; Beckmann R; Renner S; Wais U
    Klin Padiatr; 1989; 201(3):167-76. PubMed ID: 2739342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exercise on serum creatine kinase in carriers of Duchenne muscular dystrophy.
    Gaines RF; Pueschel SM; Sassaman EA; Driscoll JL
    J Med Genet; 1982 Feb; 19(1):4-7. PubMed ID: 7069744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity.
    Hudgson P; Gardner-Medwin D; Pennington RJ; Walton JN
    J Neurol Neurosurg Psychiatry; 1967 Oct; 30(5):416-9. PubMed ID: 6062992
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum creatine kinase and sulphydryl concentration after ischemic forearm work in patients and carriers of Duchenne's progressive muscular dystrophy].
    Moser H; Wiesmann U
    Klin Wochenschr; 1971 Apr; 49(8):488-94. PubMed ID: 5574169
    [No Abstract]   [Full Text] [Related]  

  • 10. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Serum creatine kinase activity in patients with Duchenne-type dystrophy and in their mothers following physical effort].
    Hetnarska L
    Neurol Neurochir Pol; 1971; 5(5):653-7. PubMed ID: 5161075
    [No Abstract]   [Full Text] [Related]  

  • 12. [Serum creatine phosphokinase activity in Duchenne-type muscular dystrophy and carriers].
    Kato F; Takahashi K
    Iryo; 1968 Dec; 22(12):1386-91. PubMed ID: 5717705
    [No Abstract]   [Full Text] [Related]  

  • 13. [Creatine phosphokinase in differential diagnosis of muscular dystrophies].
    Guglielmetti P
    G Clin Med; 1965 Feb; 46(2):155-64. PubMed ID: 5862841
    [No Abstract]   [Full Text] [Related]  

  • 14. CREATINE KINASE LEVELS IN WOMEN WHO CARRY GENES FOR THREE TYPES OF MUSCULAR DYSTROPHY.
    WILSON KM; EVANS KA; CARTER CO
    Br Med J; 1965 Mar; 1(5437):750-3. PubMed ID: 14248444
    [No Abstract]   [Full Text] [Related]  

  • 15. Letter: Serum-creatine-kinase levels in carriers of Becker muscular dystrophy.
    Skinner R; Emery AE
    Lancet; 1974 Oct; 2(7887):1023-4. PubMed ID: 4138389
    [No Abstract]   [Full Text] [Related]  

  • 16. [Discussion remarks on the work of C.M.Büsing, H. Heyck and G.G. Laudahn: "The detection of female transmitters of the Duchenne type progressive muscular dystrophy by means of discriminative analysis of various serum enzyme activities"].
    Barthelmai W
    Klin Wochenschr; 1970 Apr; 48(8):497. PubMed ID: 5519403
    [No Abstract]   [Full Text] [Related]  

  • 17. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study of progressive muscular dystrophy].
    Miyoshi K; Saijo K; Otani Y; Yoshimatsu M; Kurio Y
    Shinkei Kenkyu No Shimpo; 1965 Jul; 9(2):390-2. PubMed ID: 5893883
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of discriminant analysis of serum creatine kinase levels for detection of heterozygote carriers of Duchenne muscular dystrophy].
    Krasil'nikov VV; Labeznik TA; Shilov LA
    Genetika; 1987 Jan; 23(1):176-9. PubMed ID: 3817468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of progressive muscular dystrophy].
    van Wijngaarden GK
    Maandschr Kindergeneeskd; 1970 Feb; 37(10):293-311. PubMed ID: 4906566
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.